Artificial intelligence continues reshaping biotech research and medical diagnostics. New frameworks for improved prompt training—such as Requirement-Oriented Prompt Engineering—help users precisely instruct generative AI models, enhancing output relevance. AI platforms now orchestrate global R&D procurement and streamline drug discovery pipelines. However, regulatory and patent landscapes face challenges as AI-driven methods produce fewer in vivo validations. Industry leaders emphasize investing in comprehensive AI infrastructure to fully harness its potential in drug development, clinical trials, and patient care.